INFI News and Press, Infinity Pharmaceuticals Inc. From 03/14/19

Atossa Genetics (NASDAQ: ATOS ) +223%  on expanded access for Endoxifen. More news on: Atossa Genetics Inc., Hancock Jaffe Laboratories, Inc., Safe-T Group Ltd, Stocks on the move, Read more ...

Infinity Pharmaceuticals (NASDAQ: INFI ): FY GAAP EPS of -$0.20 beats by $0.03 . More news on: Infinity Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Consumer stocks news, , Read more ...

CAMBRIDGE, Mass. , March 14, 2019 /PRNewswire/ --  Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its full year 2018 financial results and provided an update on the company, including its progress with IPI-549, a first-in-class oral immuno-oncology product candidate t...

CAMBRIDGE, Mass. , March 14, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it has entered into a master clinical supply agreement under which Roche will supply atezolizumab (Tecentriq ® ) to Infinity for use in MARIO-3, a Phase ...

CAMBRIDGE, Mass. , March 7, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Thursday, March 14, 2019 , at 8:00 a.m. ET to review its full year 2018 financial results and provide an update on the company. A live webcast of the co...

Infinity Pharmaceuticals ( INFI +4.3% ) inks an agreement with Healthcare Royalty Partners (HCR) monetizing certain royalties from COPIKTRA (duvelisib) sales by Verastem ( VSTM -1.6% ). More news on: Infinity Pharmaceuticals, Inc., Verastem, Inc., Healthcare stocks news, Rea...

Bio-Path Holdings (NASDAQ: BPTH ) +55%  on positive prexigebersen data. More news on: Bio-Path Holdings, Inc., Abercrombie & Fitch, China Automotive Systems, Inc., Stocks on the move, Read more ...

CAMBRIDGE, Mass. , March 6, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today a royalty monetization with HealthCare Royalty Partners (HCR) for the right to receive certain royalty payments based on worldwide annual net sales of COPIKTRA™...

Gainers:  Immune Design (NASDAQ: IMDZ ) +310% . Zosano Pharma Corporation (NASDAQ: ZSAN ) +121% . Adial Pharmaceuticals (NASDAQ: ADIL ) +21% . Grand Canyon Education (NASDAQ: LOPE ) +21% . Attunity (NASDAQ: ATTU ) +19% . Career Education (NASDAQ: CECO ) +18% . Avis Budget Group ...

The following slide deck was published by Infinity Pharmaceuticals, Inc. in conjunction with this Read more ...